The effects of intermittent androgen deprivation therapy (ADT) and zoledronic acid administration on bone density in patients with prostate cancer

被引：0
|
作者：
Katznelson, L. [1 ]
Kent, K. [1 ]
Srinivas, S. [1 ]
机构：
[1] Stanford Univ, Stanford, CA 94305 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
15593
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Efficacy of androgen deprivation therapy (ADT) in patients with advanced prostate
    Ross, Robert W.
    Xie, Wanling
    Regan, Meredith M.
    Pomerantz, Mark
    Nakabayashi, Mari
    Daskivich, Timothy J.
    Sartor, Oliver
    Taplin, Mary-Ellen
    Kantoff, Philip W.
    Oh, William K.
    CANCER, 2008, 112 (06) : 1247 - 1253
  • [22] The effect of androgen deprivation therapy (ADT) on bone mineral density (BMD) in men with prostate cancer: A meta-analysis
    Lau, A.
    Vinik, O.
    Alibhai, S. M. H.
    Tomlinson, G.
    Cheung, A. M.
    OSTEOPOROSIS INTERNATIONAL, 2006, 17 : S141 - S141
  • [23] A Randomized Phase II Trial Evaluating Different Schedules of Zoledronic Acid on Bone Mineral Density in Patients With Prostate Cancer Beginning Androgen Deprivation Therapy
    Lang, Joshua M.
    Wallace, Marianne
    Becker, Jordan T.
    Eickhoff, Jens C.
    Buehring, Bjoern
    Binkley, Neil
    Staab, Mary Jane
    Wilding, George
    Liu, Glenn
    Malkovsky, Miroslav
    McNeel, Douglas G.
    CLINICAL GENITOURINARY CANCER, 2013, 11 (04) : 407 - 415
  • [24] Frequency of zoledronic acid to prevent further bone loss in osteoporotic patients requiring androgen-deprivation therapy for prostate cancer
    Wadhwa, Vivek K.
    Weston, Robin
    Parr, Nigel J.
    JOURNAL OF UROLOGY, 2007, 177 (04): : 336 - 336
  • [25] EFFECTS OF ANDROGEN DEPRIVATION THERAPY ON BONE QUALITY (TBS) IN PATIENTS WITH PROSTATE CANCER
    Garcia-Cirera, S.
    Casado, E.
    Munoz, J.
    Del Rio, L.
    Arevalo, M.
    Rusinol, M.
    Navarro, N.
    Parejo, V.
    Gratacos, J.
    OSTEOPOROSIS INTERNATIONAL, 2020, 31 (SUPPL 1) : S459 - S459
  • [26] EFFECTS OF ANDROGEN DEPRIVATION THERAPY ON BONE QUALITY (TBS) IN PATIENTS WITH PROSTATE CANCER
    Garcia-Cirera, S.
    Casado, E.
    Munoz, J.
    Del Rio, L.
    Arevalo, M.
    Rusinol, M.
    Navarro, N.
    Parejo, V.
    Gratacos-Masmitja, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1187 - 1188
  • [27] Androgen deprivation therapy in patients with prostate cancer and changes in bone mineral density.
    Alferos, MG
    Yaturu, S
    JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 : S243 - S243
  • [28] Changes in bone mineral density in patients with prostate cancer treated with androgen deprivation therapy
    Bernat, MM
    Pasini, J
    Marekovic, Z
    COLLEGIUM ANTROPOLOGICUM, 2005, 29 (02) : 589 - 591
  • [29] Nutritional program among patients with prostate cancer receiving androgen deprivation therapy (ADT)
    Lages, Paulo Sergio
    Pivato de Almeida, Daniel Vargas
    Bergerot, Cristiane Decat
    Bergerot, Paulo Gustavo
    Barbosa, Michelle
    Dutra, Camila Rosa
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [30] Effects of androgen deprivation therapy on bone health in prostate cancer
    McDonough, Allyson K.
    Teng, Gim G.
    Abbott, Joel
    Nair, Raj
    Amling, Christopher
    Colli, Jan
    Fiveash, John B.
    Lopez, Robert
    Urban, Donald
    Curtis, Jeffrey R.
    Saag, Kenneth
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S741 - S741
12345